
Did you experience an empty feeling during your last Twitter session? Thinking that compared to other media, there’s just something missing?
Well don’t fret because that emptiness will soon be filled. With advertisements, says Anamitra Banerji, head of product management and monetization at Twitter.
We all know about the recent “buzz” surrounding social media. But how do advertisements fit into the social sphere? Should you simply place your ad for consumers to see (think Facebook banner ads)? Or have consumers become so saturated with advertisements that you need to take a new approach and let them find their own ways to connect with you? Facebook recently nixed banner ads and now encourages its users to become a “fan” of their favorite brands.
Media Post reports that Twitter will be the next social network to join the “age of advertising” by launching an official advertising platform later this month. Banerji said the platform is currently in the “test phase,” and stated, “people are constantly talking and engaging with brands, sharing their feedback. What if brands start to participate?”
So how will tweeple respond? Will the infusion of advertisements on the social network drive away its users? Or will the ad platform attract sweeple (sweet twitter people) with its capability to target them as consumers?
The responses are split thus far. Some Twitter users claim they will discontinue their use of Twitter, while others feel the platform will provide easier ways to communicate with brands and allow them to tell brands exactly what the want. Unlike banner ads, Twitter ads will be mixed in your Twitter stream, which means, for the time being, the twitterer might actually notice them.
So what does this mean for pharma?
If come springtime I’m tweeting about my running nose and watery eyes, will an advertisement for Allegra pop up in my Twitter stream? Is that approaching the line of Big Brother or is it just target marketing?
Will pharma companies brave the twitosphere’s new advertising realm? Will that backfire, or change pharma marketing as we know it?